Note: Dermtech's revenues are gauged from an analysis of company filings.
Dermtech has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
December 5, 2017
Complete list of funding rounds and total amounts in the Company Report
Dermtech's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Dermtech Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Dermtech is developing and marketing.
Dermtech's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
KEROME Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans
KEROSIGHT Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans
NEVOME Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans
Patent applications show Dermtech's intellectual property,
its current capabilities and future direction.
Dermtech has applied for 10 patents since 2009.
Dermtech's most recent patent was filed in January 2016 for Characterization Of Melanoma Using A Molecular Signature.The present disclosure provides methods for characterizing melanoma in a subject by analyzing genes or gene expression products obtained from the subject. The present disclosure provides methods for distinguishing melanoma in situ from invasive melanoma. The disclosure includes non-invasive methods for obtaining genes or gene expression products from a pigmented skin lesion of a subject.
Complete list of patent applications
Determine whether Dermtech grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Dermtech is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Dermtech vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Dermtech, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are in the same general field as Dermtech and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.